Author(s)

Yun Wang¹, Shiqi Song¹, Jian Huang^1,2*

¹Department of Pathological Diagnosis and Research Center, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
²Guangzhou Huayin Health Medical Group Co., Ltd., Guangzhou, China.

With the changes in disease spectrum and the popularization of screening of low-dose spiral CT (CT) in the chest, more and more pulmonary nodules have been detected, most of which are bipulmonary multiple nodules. The existence of multiple pulmonary nodules means that it may be a pathological state of benign and malignant co-existence. The origin and evolution of pulmonary nodules in different histopathological states have a great impact on the choice of treatment methods. In recent years, the rise of immunotherapy has brought a breakthrough in the treatment of refractory lung cancer. However, some patients are still ineffective in immunotherapy, which may be related to the immune microenvironment where nodules are proportioned in different components in different pathological states. This review article mainly predicts the development process of nodules by analyzing the origin of multiple pulmonary nodules and the immune microenvironment of nodules in different pathological conditions, so as to provide guidance for clinical treatment.

Lung Nodules, Originate, Pathology, Immune Microenvironment

Wang, Y. , Song, S. and Huang, J. (2023) Clinical and Pathological Research Status of Multiple Pulmonary Nodules. Journal of Cancer Therapy, 14, 170-181. doi: 10.4236/jct.2023.144016.